E062 Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2019-04, Vol.58 (Supplement_3)
Main Authors: Lwin, May Nwe, Cole, Zoe, Holroyd, Chris, O'Reilly, Alexandra, Hill, Diane, Kiely, Patrick D W, Edwards, Christopher
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1450-32f7600009daf249fbb1f7ac0eb2096a681e8d88cc0f82b407ac2d9957b36d3b3
cites
container_end_page
container_issue Supplement_3
container_start_page
container_title Rheumatology (Oxford, England)
container_volume 58
creator Lwin, May Nwe
Cole, Zoe
Holroyd, Chris
O'Reilly, Alexandra
Hill, Diane
Kiely, Patrick D W
Edwards, Christopher
description
doi_str_mv 10.1093/rheumatology/kez110.060
format article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_rheumatology_kez110_060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/rheumatology/kez110.060</oup_id><sourcerecordid>10.1093/rheumatology/kez110.060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1450-32f7600009daf249fbb1f7ac0eb2096a681e8d88cc0f82b407ac2d9957b36d3b3</originalsourceid><addsrcrecordid>eNqNkM1KAzEUhYMoWKvPYF5gND_T-XGnpf5AwY2uhySTdG47TUqSUepK8A18RJ_ESFVcuroH7j3ncD-ETik5o6Tm577Tw1pE17vF9nylX2hakILsoRHNC5YRztn-r2b5IToKYUkImVBejdD7jBTs4_XtSgTdg9VYdcILFbWHEEEF7AzeiAjaxoCfIXb4pw9aLHzsPEQIOMSkwS5w7DReCjsEvAKbMjHYDiRE57EUHlS6tiAvsNeiz3owGjsZtH9KFc6mmKHdHqMDI_qgT77nGD1ezx6mt9n8_uZuejnPFM0nJOPMlEX6g9StMCyvjZTUlEIRLRmpC1FUVFdtVSlFTMVkTtKOtXU9KSUvWi75GJW7XOVdCF6bZuNhLfy2oaT5Qtv8Rdvs0DYJbXKyndMNm3-bPgHG84ka</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>E062 Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>Lwin, May Nwe ; Cole, Zoe ; Holroyd, Chris ; O'Reilly, Alexandra ; Hill, Diane ; Kiely, Patrick D W ; Edwards, Christopher</creator><creatorcontrib>Lwin, May Nwe ; Cole, Zoe ; Holroyd, Chris ; O'Reilly, Alexandra ; Hill, Diane ; Kiely, Patrick D W ; Edwards, Christopher</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kez110.060</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1450-32f7600009daf249fbb1f7ac0eb2096a681e8d88cc0f82b407ac2d9957b36d3b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lwin, May Nwe</creatorcontrib><creatorcontrib>Cole, Zoe</creatorcontrib><creatorcontrib>Holroyd, Chris</creatorcontrib><creatorcontrib>O'Reilly, Alexandra</creatorcontrib><creatorcontrib>Hill, Diane</creatorcontrib><creatorcontrib>Kiely, Patrick D W</creatorcontrib><creatorcontrib>Edwards, Christopher</creatorcontrib><title>E062 Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study</title><title>Rheumatology (Oxford, England)</title><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqNkM1KAzEUhYMoWKvPYF5gND_T-XGnpf5AwY2uhySTdG47TUqSUepK8A18RJ_ESFVcuroH7j3ncD-ETik5o6Tm577Tw1pE17vF9nylX2hakILsoRHNC5YRztn-r2b5IToKYUkImVBejdD7jBTs4_XtSgTdg9VYdcILFbWHEEEF7AzeiAjaxoCfIXb4pw9aLHzsPEQIOMSkwS5w7DReCjsEvAKbMjHYDiRE57EUHlS6tiAvsNeiz3owGjsZtH9KFc6mmKHdHqMDI_qgT77nGD1ezx6mt9n8_uZuejnPFM0nJOPMlEX6g9StMCyvjZTUlEIRLRmpC1FUVFdtVSlFTMVkTtKOtXU9KSUvWi75GJW7XOVdCF6bZuNhLfy2oaT5Qtv8Rdvs0DYJbXKyndMNm3-bPgHG84ka</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Lwin, May Nwe</creator><creator>Cole, Zoe</creator><creator>Holroyd, Chris</creator><creator>O'Reilly, Alexandra</creator><creator>Hill, Diane</creator><creator>Kiely, Patrick D W</creator><creator>Edwards, Christopher</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20190401</creationdate><title>E062 Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study</title><author>Lwin, May Nwe ; Cole, Zoe ; Holroyd, Chris ; O'Reilly, Alexandra ; Hill, Diane ; Kiely, Patrick D W ; Edwards, Christopher</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1450-32f7600009daf249fbb1f7ac0eb2096a681e8d88cc0f82b407ac2d9957b36d3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lwin, May Nwe</creatorcontrib><creatorcontrib>Cole, Zoe</creatorcontrib><creatorcontrib>Holroyd, Chris</creatorcontrib><creatorcontrib>O'Reilly, Alexandra</creatorcontrib><creatorcontrib>Hill, Diane</creatorcontrib><creatorcontrib>Kiely, Patrick D W</creatorcontrib><creatorcontrib>Edwards, Christopher</creatorcontrib><collection>CrossRef</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lwin, May Nwe</au><au>Cole, Zoe</au><au>Holroyd, Chris</au><au>O'Reilly, Alexandra</au><au>Hill, Diane</au><au>Kiely, Patrick D W</au><au>Edwards, Christopher</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>E062 Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><date>2019-04-01</date><risdate>2019</risdate><volume>58</volume><issue>Supplement_3</issue><issn>1462-0324</issn><eissn>1462-0332</eissn><pub>Oxford University Press</pub><doi>10.1093/rheumatology/kez110.060</doi></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)
issn 1462-0324
1462-0332
language eng
recordid cdi_crossref_primary_10_1093_rheumatology_kez110_060
source Oxford Journals Online; Alma/SFX Local Collection
title E062 Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A52%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=E062%E2%80%83Baseline%20characteristics%20of%20patients%20with%20rheumatoid%20arthritis%20starting%20the%20janus%20kinase%20inhibitor%20baricitinib:%20real-life%20observation%20study&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Lwin,%20May%20Nwe&rft.date=2019-04-01&rft.volume=58&rft.issue=Supplement_3&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kez110.060&rft_dat=%3Coup_cross%3E10.1093/rheumatology/kez110.060%3C/oup_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1450-32f7600009daf249fbb1f7ac0eb2096a681e8d88cc0f82b407ac2d9957b36d3b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/rheumatology/kez110.060&rfr_iscdi=true